Thursday, June 4, 2026

#HALO

48 articles

Halozyme Therapeutics And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Feb 10, 2024

Halozyme Therapeutics And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Dec 1, 2023

Halozyme Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Nov 30, 2023

SCYNEXIS And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

SCYNEXIS And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Nov 16, 2023

Halozyme Therapeutics And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Nov 6, 2023

Halozyme Therapeutics And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Oct 27, 2023

Xylem And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Xylem And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Oct 9, 2023

Universal Technical Institute And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Universal Technical Institute And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Oct 6, 2023

Trip.com And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Trip.com And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Sep 28, 2023

Live Ventures Incorporated And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Live Ventures Incorporated And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Aug 4, 2023

Xylem And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Xylem And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Aug 3, 2023

ProLogis And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ProLogis And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Jul 16, 2023

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•May 12, 2023

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•May 4, 2023

OneSpaWorld Holdings Limited And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

OneSpaWorld Holdings Limited And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•May 4, 2023

Halozyme Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Apr 16, 2023

Esquire Financial Holdings And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Esquire Financial Holdings And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Mar 22, 2023

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Mar 1, 2023

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Feb 7, 2023

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Jan 31, 2023